Cellectis (CLLS) Interest Expenses (2015 - 2026)

Cellectis' (CLLS) quarterly Interest Expenses came in at -$4.4 million in Q1 2026, up 56.63% year-on-year from -$2.8 million in Q1 2025, and down 104.9% quarter-over-quarter from $90.7 million in Q4 2025.

Cellectis (CLLS) Interest Expenses (2015 - 2026) Analysis & Trends

Cellectis' Interest Expenses history runs 12 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 56.63% year-over-year to -$4.4 million in Q1 2026; TTM through Mar 2026 was $55.7 million, a 1555.4% increase from a year earlier, with the FY2025 full-year figure at $51.1 million, up 136.25% from the prior year.
  • Interest Expenses eased to -$4.4 million in Q1 2026 per CLLS's latest filing, from $90.7 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $90.7 million in Q4 2025 and bottomed at -$19.7 million in Q2 2025.
  • The 5-year median for Interest Expenses is -$1.7 million (2022), against an average of $10.4 million.
  • Across the five-year window, Interest Expenses sank 1134.55% in 2022 and jumped 2221.78% in 2023, its largest moves.
  • Year by year, Interest Expenses stood at $22.0 million in 2022, then surged by 190.28% to $63.7 million in 2023, then slipped by 28.35% to $45.7 million in 2024, then surged by 98.68% to $90.7 million in 2025, then plunged by 104.9% to -$4.4 million in 2026.
  • Per Business Quant, the three latest CLLS Interest Expenses figures stand at -$4.4 million (Q1 2026), $90.7 million (Q4 2025), and -$10.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Cellectis 285.50 Mn 99.83 Mn - -4.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.44 Mn
Mar 31, 2026 -4.44 Mn
Dec 31, 2025 90.72 Mn
Dec 31, 2025 90.72 Mn
Sep 30, 2025 -10.91 Mn
Sep 30, 2025 -10.91 Mn
Jun 30, 2025 -19.70 Mn
Jun 30, 2025 -19.70 Mn
Mar 31, 2025 -10.25 Mn
Mar 31, 2025 -10.25 Mn
Dec 31, 2024 45.66 Mn
Dec 31, 2024 45.66 Mn
Sep 30, 2024 -15.41 Mn
Sep 30, 2024 -15.41 Mn
Jun 30, 2024 -16.65 Mn
Jun 30, 2024 -16.65 Mn
Mar 31, 2024 -3.14 Mn
Mar 31, 2024 -3.14 Mn
Dec 31, 2023 63.73 Mn
Dec 31, 2023 63.73 Mn